xx123

 

If you are having trouble viewing this email, please click here
 

 

October 10, 2017

 

University of Maryland receives $219.5M gift from Clark Foundation, largest in school's history - Baltimore Business Journal
 

The University of Maryland will receive a $219.5 million donation from the A. James and Alice B. Clark Foundation created by the late contracting titan James Clark.

Read More

 

 

 

TEDCO Awards $1 Million in New Stem Cell Projects
 

The Maryland Stem Cell Research Commission (Commission) approved funding for four awards totaling $1,060,000. With the robust activity in stem cell research in Maryland, the Commission approved the first of two rounds of applications this year for the Validation and Commercialization Programs to accelerate getting solutions to patients.

Read More

 

 

 

Circulomics Receives Two SBIR Grants Totaling over $1.7M
 

Circulomics, a Baltimore, MD-based biotechnology startup, received two SBIR grants totaling over $1.7M.

The company will use the funds to develop new applications of its Nanobind DNA/RNA extraction technology.

Read More

 

 

 

Rhythm Pharma IPO goes over the top, snags $120M in latest sign the biotech window is wide open – ENDPOINTS NEWS
 

Rhythm Pharmaceuticals $RYTM became the latest biotech to tap into a buoyant market, raising $120 million in an IPO that went over the range at $17 a share. And they can add substantially to that if the underwriters pick up another million shares on the table.

Read More

 

 

 

Emergent BioSolutions Awarded U.S. Department of State Contract Valued at Up to $25 Million to Supply Nerve Agent Antidote Auto-Injector NYSE:EBS
 

Emergent BioSolutions Inc. (NYSE:EBS) today announced that it has been awarded a contract valued at up to approximately $25 million by the U.S. Department of State to supply TROBIGARD™ (Atropine Sulfate [2mg]/Obidoxime Chloride [220mg]) auto-injector, a drug and device combination product for emergency use in the event of nerve agent or organophosphate poisoning. Trobigard is designed for intramuscular self- or buddy-administration of atropine sulfate and obidoxime chloride for pre-hospital intervention.

Read More

 

 

 

 

Qiagen achieves ISO certification for state-of-the-art quality in forensics
 

Qiagen has announced that its manufacturing and supply chain for consumables and other products for forensic and human identity testing has been certified by Bureau Veritas, a leading inspection agency, as meeting the latest international standards for products used in forensic testing.

Read More

 

 

 

BioMarker Strategies Announces Phase I National Cancer Institute Grant to Develop Companion Diagnostic to Identify Patients with Head and Neck Cancer Who Are Most Likely to Respond to Treatment with Cetuximab | Business Wire
 

BioMarker Strategies, LLC today announced that the National Cancer Institute (NCI) has awarded the Company a Phase I Small Business Innovation Research (SBIR) grant for development of a pathway-based companion diagnostic test to identify patients with head and neck squamous cell carcinoma (HNSCC) who are most likely to respond to treatment with cetuximab. The grant will provide $299,000 in research support.

Read More

 

 

 

NEBGH President & CEO Laurel Pickering to Join Leading Digital Health Company, WellDoc, as Chief Revenue Officer
 

WellDoc®, a leading digital health company, announced today the appointment of Laurel Pickering, president and CEO of Northeast Business Group on Health (NEBGH), as the Company’s new Chief Revenue Officer (CRO). Ms. Pickering selected WellDoc as her next opportunity after spending nearly 25 years at the helm of NEBGH, an employer-led coalition of healthcare leaders and other stakeholders. Ms. Pickering will join the WellDoc team in October.

Read More

 

 

 

Sorrento Therapeutics Appoints Mr. Dorman Followwill And Mr. Dave Lemus To The Board Of Directors | Markets Insider
 

Effective September 26, 2017, the Board of Directors (the "Board") of Sorrento Therapeutics, Inc. (Nasdaq: SRNE) appointed each of Dorman Followwill and David Lemus as an independent director of the Company.

Read More

 

 

 

Osiris Announces a Peer-Reviewed Publication Reporting the Use of Placental Membranes for Refractory Cutaneous Sinus Tracts of Surgical Origin
 

Osiris Therapeutics, Inc. (Pink Sheets: OSIR), a leading regenerative medicine company focused on developing and marketing products for wound care, orthopedics, and sports medicine, announced today that a new peer reviewed manuscript entitled “Placental Membranes for Management of Refractory Cutaneous Sinus Tracts of Surgical Origin: A Pilot Study” has been published in The Journal of the American College of Clinical Wound Specialists and is available online.

Read More

 

 

 

 

Study: DC-area ranks 10th in venture investment - Technical.ly DC
 

We know from following the Rise of the Rest that D.C. isn’t in the top three for metros venture capital investments, but a new study said it makes the top 10.

Read More

 

 

 

The Geographic Concentration of Venture Capital - CityLab
 

When it comes to high-tech startups, we hear a lot about the so-called “rise of the rest.” As the nation’s leading centers of high-tech industry—places like the San Francisco Bay Area, New York City, Boston, and Seattle—have become increasingly expensive to live in, the argument goes, talented techies, entrepreneurs, and startups are moving to less expensive places like Portland, Pittsburgh, Detroit, Nashville, Las Vegas, and others.

Read More

 

 

 

Universities key to regional cooperation among Md., D.C. and Va. - Baltimore Sun
 

Despite the jurisdictional posturing in Maryland, Virginia and Washington D.C. over a possible Amazon headquarters, a new FBI building or a national football stadium, the recent joint trade mission to Canada by their respective leaders — along with efforts such as the Greater Washington Board of Trade holding its summit at the Pendry Hotel in Baltimore — all augur well for better regional cooperation.

Read More

 

 

 

CIT Announces FY2018 Solicitation for Commonwealth Research Commercialization Fund
 

The Center for Innovative Technology (CIT) announced today the Commonwealth Research Commercialization Fund (CRCF) Request for Proposals (RFP) for FY2018.

Read More

 

 

 

Visbiome probiotic approved for IBS in Canada - Healio
 

Health Canada has approved the probiotic Visbiome as a Natural Health Product for treating symptoms of irritable bowel syndrome in adults and children aged older than 5 years, the manufacturer announced.

Read More

 

 

 

Meet DC's newest incubator: Accelspace - Technical.ly DC
 

What happens to startups when they’ve outgrown coworking, but aren’t ready a whole office suite? There’s an incubator for that.

Accelspace is #dctech’s latest incubator, aimed at high-growth, mid-level, startups. Currently the incubator has offices in downtown D.C. and Crystal City.

Read More

 

 

 

Rock Health: 16% of digital health companies funded in Q3 2017 led by women - MedCity News
 

A digital health report from Rock Health showed that women-led companies and geographic diversity continued to build in the third quarter. In the three months through September 30, of the 84 companies that raised $1.2 billion, 16 percent were led by women.

Read More

 

 

 

Science - from Academia to Innovation: Perspectives from Israel
 

The MIDC and ScienceAbroad, the organization of Israeli scientists abroad, jointly present a revealing program on the bio-tech entrepreneurial ecosystem of Israel and how it created “The Startup Nation,” featuring prominent Israeli scientific and entrepreneurial leaders.

Wednesday, Nov. 1st 5:30-7:30 p.m., Hosted by LifeBridge Health, Baltimore, MDThursday, Nov. 2nd 5:30-7:30 p.m., Suburban Hospital, Bethesda, MD

Read More

 

 

 

2017 Technology Showcase | ACG National Capital
 

When: October 25, 2017 7:30 AM - 12 PM

Where: MITRE 7525 Colshire Drive McLean, VA 22102 United States

The Technology Showcase emphasizes the National Capital area's culture of technology innovation and leadership. The conference also highlights Washington's unique competitive advantage for commercial technology companies: access to policy-makers, government technology buyers, and national security services.

Read More

 

 

 

Dodgy clinics, shoddy science and false hopes: how stem cell research is being threatened by charlatans and unproven cures | South China Morning Post
 

The credibility of stem cell research is at risk because of charlatans and dodgy clinics peddling unproven cures for diseases, according to a group of eminent scientists in the field.

Read More

 

 

 

Bayer eyes Korea’s ‘deep tech’ startups for digital health care push
 

[THE INVESTOR] In the age of “digital health care,” high-tech wearables, cutting-edge medical devices and integrated apps combined with major breakthroughs in data computing and analytics capabilities are set to pave new frontiers in the health care sector.

Read More

 

 

 

U of Washington, Tsinghua launch innovation-focused programs as part of Microsoft-funded partnership
 

A new academic enterprise, born of a partnership between the University of Washington and China’s Tsinghua University -- and seeded with $40 million in funding from Microsoft -- welcomed its first class of master’s students this fall.

Read More

 

 

 

What’s next for pharma innovation in China | McKinsey & Company
 

Three prominent Chinese executives discuss the progress of local companies in drug innovation and the evolving regulatory environment.

Read More

 

 

 

2017 Academic Drug Discovery
 

ADDC and ASPET are joining together again for the 2nd Colloquium on Academic Drug Discovery. We are calling this meeting “Fueling Innovation: Public Programs Driving Drug Discovery” and holding it as a standalone event on the NIH campus in Bethesda, MD on October 12, 13, 2017. The first collaborative event held by these two scientific societies in April 2016 and was a terrific success.

Read More

 

 

 

Scientific Reproducibility: Addressing Cell Line Authentication, Cross Contamination, Mycoplasma Detection and Antibody Characterization/Validation
 

Bio-Trac® Training Programs is pleased to be conducting a Hands-On "Scientific Reproducibility & Rigor: Antibody Characterization/Validation; Cell Line Authentication; Mycoplasma Detection" training workshop on Wednesday, October 18 – Friday, October 20, 2017 at the MC Bioscience Education Center in Germantown, MD.

Read More

 

 

 

The Biotech/Health Invitational Golf Tournament
 

Welcome to the 2017 Biotech / Health Invitational, a DogDenGolf managed event that is being supported by top executives at Medimmune, other Biotechnology / Health companies and Vendors in the region. This year's event will be held on October 23, 2017, at Cattail Creek Country Club in Glenwood, MD and will determine the Biotech / Health Executive Golfers of the Year.   

Proceeds from this event will benefit Zaching Against Cancer Foundation (ZACF), a 501(c)(3) non-profit foundation established to provide support to cancer patients and their support networks through scholarships, research and outreach. Money raised by ZACF goes toward several college scholarships, an internship and donation to cancer research and outreach organizations.

Read More

 

 

Upcoming Events

BioBowl (10/10 deadline to register)
Oct 12
 

 

 

 

Scientific Reproducibility: Addressing Cell Line Authentication, Cross Contamination, Mycoplasma Detection and Antibody Characterization/Validation
Oct 18
 

 

 

 
 

 

 

 

Home | About BHI | BHI News | Programs | Partners | Contact

Copyright © BioHealth Innovation 2017
All Rights Reserved.